Medicenna Therapeutics Corp. (MDNA.TO)

CAD 1.75

(-2.23%)

Revenue Summary of Medicenna Therapeutics Corp.

  • Medicenna Therapeutics Corp.'s latest annual revenue in 2023 was - CAD , down 0.0% from previous year.
  • Medicenna Therapeutics Corp.'s latest quarterly revenue in 2024 Q1 was 5000.00 CAD , down 0.0% from previous quarter.
  • Medicenna Therapeutics Corp. reported a annual revenue of - CAD in annual revenue 2022, down 0.0% from previous year.
  • Medicenna Therapeutics Corp. reported a annual revenue of - CAD in annual revenue 2021, down 0.0% from previous year.
  • Medicenna Therapeutics Corp. reported a quarterly revenue of - CAD for 2023 FY, down 0.0% from previous quarter.
  • Medicenna Therapeutics Corp. reported a quarterly revenue of - CAD for 2023 Q3, down 0.0% from previous quarter.

Annual Revenue Chart of Medicenna Therapeutics Corp. (2023 - 2013)

Historical Annual Revenue of Medicenna Therapeutics Corp. (2023 - 2013)

Year Revenue Revenue Growth
2023 - CAD 0.0%
2022 - CAD 0.0%
2021 - CAD 0.0%
2020 - CAD 0.0%
2019 - CAD 0.0%
2018 - CAD 0.0%
2017 - CAD 0.0%
2016 - CAD 0.0%
2015 - CAD 0.0%
2014 - CAD 0.0%
2013 - CAD 0.0%

Peer Revenue Comparison of Medicenna Therapeutics Corp.

Name Revenue Revenue Difference
Appili Therapeutics Inc. 827.4 Thousand CAD 100.0%
Eupraxia Pharmaceuticals Inc. - CAD NaN%
Helix BioPharma Corp. - CAD NaN%
Microbix Biosystems Inc. 16.51 Million CAD 100.0%
Satellos Bioscience Inc. - CAD NaN%
Oncolytics Biotech Inc. - CAD NaN%
Sernova Corp. - CAD NaN%